Effect and Safety of Phytosomal Curcumin Supplementation on Migraine Patients: A Randomized, Double-Blind and Placebo-Controlled Trial
- 24 October 2025
- journal article
- research article
- Published by Springer Nature in Chinese Journal of Integrative Medicine
- Vol. 31 (11) , 963-972
Abstract
Objective To investigate the effect and safety of phytosomal curcumin supplementation on patients with migraine. Methods In this randomized, double-blind and placebo-controlled trial, 70 patients suffered from migraine without aura were randomized into 2 groups to receive 250 mg/d of phytosomal curcumin (intervention group) or maltodextrin (placebo group) for 8 weeks, 35 cases per group. All patients in both groups received their standard treatment and common medications. The severity, duration, frequency of headaches, quality of life (QoL), mental status, headache impact, and sleep quality of patients were assessed before and after treatment. Adverse effects were also assessed. Results Sixty-five patients completed the trial (33 in the intervention group and 32 in the placebo group). Phytosomal curcumin supplementation significantly reduced severity, duration and frequency of migraine attacks, stress score, and headache impact, and improved QoL and sleep quality of patients in the intervention group, compared with the placebo group (PP0.05). No adverse effects had been reported in response to the intervention. Conclusion Phytosomal curcumin as a safe supplement had a beneficial effect on migraine symptoms, stress level, as well as the sleep quality and QoL in patients with migraine. (Trial registration No. IRCT20201129049534N2)Keywords
This publication has 39 references indexed in Scilit:
- The regulating effect of curcumin on NF-κB pathway in neurodegenerative diseases: a review of the underlying mechanismsInflammopharmacology, 2024
- The impact of curcumin on migraine: A comprehensive reviewBiomedicine & Pharmacotherapy, 2023
- Curcumin‐piperine co‐supplementation and human health: A comprehensive review of preclinical and clinical studiesPhytotherapy Research, 2023
- Effect of nano‐curcumin on various diseases: A comprehensive review of clinical trialsBioFactors, 2023
- The clinical use of curcumin on neurological disorders: An updated systematic review of clinical trialsPhytotherapy Research, 2021
- A Comprehensive Review on the Role of Genetic Factors in the Pathogenesis of MigraineJournal of Molecular Neuroscience, 2021
- NF-κB pathway activation during endothelial-to-mesenchymal transition in a rat model of doxorubicin-induced cardiotoxicityBiomedicine & Pharmacotherapy, 2020
- Migraine: Stigma in SocietyCurrent Pain and Headache Reports, 2019
- Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studiesBiomedicine & Pharmacotherapy, 2017
- Reliability and validity of the Persian version of the Pittsburgh Sleep Quality Index (PSQI-P)Sleep and Breathing, 2011